Biotech · Private company · Watertown, MA, US
Aldatu Biosciences, Inc.
Track this companyFree. Adds Aldatu Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards6
- PANDAA for universal, pan-lineage molecular detection of filoviruses to enable rapid epidemic response.Fiscal year 2026 · $997KNIH RePORTER 2R44AI172551-04 · fetched Nov 12, 2026
- PANDAA for universal, pan-lineage molecular detection of Crimean-Congo Hemorrhagic Fever virus.Fiscal year 2026 · $960KNIH RePORTER 5R44AI157650-05 · fetched Nov 12, 2026
- PANDAA for universal, pan-lineage molecular detection of Crimean-Congo Hemorrhagic Fever virus.Fiscal year 2025 · $975KNIH RePORTER 5R44AI157650-04 · fetched Nov 12, 2026
- PANDAA for universal, pan-lineage molecular detection of Crimean-Congo Hemorrhagic Fever virus.Fiscal year 2024 · $986.9KNIH RePORTER 2R44AI157650-03 · fetched Nov 12, 2026
- PANDAA for universal, pan-lineage molecular detection of filoviruses to enable rapid epidemic response.Fiscal year 2024 · $943.2KNIH RePORTER 5R44AI172551-03 · fetched Nov 12, 2026
- Commercialization of PANDAA qDx for rapid drug resistance genotyping of protease inhibitor ART failures in resource-limited settings.Fiscal year 2024 · $957.8KNIH RePORTER 5SB1AI128974-06 · fetched Nov 12, 2026